Canadian Study on the Association of Pessary With Progesterone

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

October 6, 2022

Study Completion Date

October 6, 2022

Conditions
Preterm BirthShort Cervix
Interventions
DRUG

Prometrium

Intravaginal use, off label, of Prometrium

DEVICE

Dr. Arabin, cerclage pessary perforated

A Dr. Arabin, cerclage pessary perforated will be inserted participants diagnosed with a short cervix

Trial Locations (8)

Unknown

Kingston General Hospital, Kingston

St.Mary's Hospital Center, Montreal

K1H 8L6

Ottawa Hospital, Ottawa

H2X 0C1

Centre hospitalier de l'Université de Montréal, Montreal

H3T 1C5

CHU Sainte-Justine, Montreal

H3T 1E2

CIUSSS du Centre Ouest-de-l'Île-de Montréal, Montreal

G1V 4G2

CHU de Québec-Université Laval, Québec

J1H 5N4

Université de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

collaborator

CHU de Quebec-Universite Laval

OTHER

collaborator

St. Justine's Hospital

OTHER

collaborator

Jewish General Hospital

OTHER

collaborator

The Ottawa Hospital

OTHER

collaborator

Queen's University

OTHER

lead

Université de Sherbrooke

OTHER

NCT03227705 - Canadian Study on the Association of Pessary With Progesterone | Biotech Hunter | Biotech Hunter